Follow
Oliver Kent
Oliver Kent
Princess Margaret Cancer Center
No verified email
Title
Cited by
Cited by
Year
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
TC Chang, EA Wentzel, OA Kent, K Ramachandran, M Mullendore, ...
Molecular cell 26 (5), 745-752, 2007
24762007
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
OA Kent, JT Mendell
Oncogene 25 (46), 6188-6196, 2006
8882006
Nuclear miRNA regulates the mitochondrial genome in the heart
S Das, M Ferlito, OA Kent, K Fox-Talbot, R Wang, D Liu, N Raghavachari, ...
Circulation research 110 (12), 1596-1603, 2012
3982012
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice
D Pramanik, NR Campbell, C Karikari, R Chivukula, OA Kent, JT Mendell, ...
Molecular cancer therapeutics 10 (8), 1470-1480, 2011
3762011
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
OA Kent, RR Chivukula, M Mullendore, EA Wentzel, G Feldmann, KH Lee, ...
Genes & development 24 (24), 2754-2759, 2010
3672010
Lessons from miR-143/145: the importance of cell-type localization of miRNAs
OA Kent, MN McCall, TC Cornish, MK Halushka
Nucleic acids research 42 (12), 7528-7538, 2014
2162014
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
OA Kent, K Fox-Talbot, MK Halushka
Oncogene 32 (20), 2576-2585, 2013
1562013
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
OA Kent, ME Mullendore, EA Wentzel, P López-Romero, AC Tan, ...
Cancer biology & therapy 8 (21), 2013-2024, 2009
1482009
MicroRNA profiling of diverse endothelial cell types
MN McCall, OA Kent, J Yu, K Fox-Talbot, AL Zaiman, MK Halushka
BMC medical genomics 4, 1-13, 2011
1332011
Role of pri-miRNA tertiary structure in miR-17~ 92 miRNA biogenesis
SG Chaulk, GL Thede, OA Kent, Z Xu, E Gesner, RA Veldhoen, ...
RNA biology 8 (6), 1105-1114, 2011
1192011
Divergent effects of miR‐181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets
S Das, M Kohr, B Dunkerly‐Eyring, DI Lee, D Bedja, OA Kent, AKL Leung, ...
Journal of the American Heart Association 6 (3), e004694, 2017
1062017
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1
J Cullis, D Meiri, MJ Sandi, N Radulovich, OA Kent, M Medrano, ...
Cancer cell 25 (2), 181-195, 2014
1062014
Functional integration of microRNAs into oncogenic and tumor suppressor pathways
CD Lotterman, OA Kent, JT Mendell
Cell Cycle 7 (16), 2493-2499, 2008
1002008
Crystal structure of a core spliceosomal protein interface
MJ Schellenberg, RA Edwards, DB Ritchie, OA Kent, MM Golas, H Stark, ...
Proceedings of the National Academy of Sciences 103 (5), 1266-1271, 2006
892006
Transcriptional regulation of miR-31 by oncogenic KRAS mediates metastatic phenotypes by repressing RASA1
OA Kent, JT Mendell, R Rottapel
Molecular Cancer Research 14 (3), 267-277, 2016
862016
Identifying targets of miR-143 using a SILAC-based proteomic approach
Y Yang, R Chaerkady, K Kandasamy, TC Huang, LDN Selvan, ...
Molecular Biosystems 6 (10), 1873-1882, 2010
822010
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2
Y Matsumoto, J La Rose, OA Kent, MJ Wagner, M Narimatsu, AD Levy, ...
The Journal of clinical investigation 126 (12), 4482-4496, 2016
742016
Early organization of pre-mRNA during spliceosome assembly
OA Kent, AM MacMillan
nature structural biology 9 (8), 576-581, 2002
662002
Characterization of a U2AF-independent commitment complex (E′) in the mammalian spliceosome assembly pathway
OA Kent, DB Ritchie, AM MacMillan
Molecular and cellular biology 25 (1), 233-240, 2005
632005
Structuring of the 3′ splice site by U2AF65
OA Kent, A Reayi, L Foong, KA Chilibeck, AM MacMillan
Journal of Biological Chemistry 278 (50), 50572-50577, 2003
542003
The system can't perform the operation now. Try again later.
Articles 1–20